| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/10/07 | 05 : 07 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/29 | 05 : 30 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 08 : 18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 06 : 25 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 25 | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 23 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 22 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 21 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 20 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 19 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 18 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 17 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 16 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 15 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/27 | 05 : 14 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/26 | 21 : 59 | GlobeNewswire Inc. | Biogen Completes Acquisition of Reata Pharmaceuticals | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/22 | 05 : 05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RETA | Reata Pharmaceuticals Inc |
| 2023/09/21 | 23 : 08 | Business Wire | Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc. | NASDAQ:RETA | Reata Pharmaceuticals Inc |